These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 31963924)

  • 1. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
    McCarthy DM
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa.
    Tatsuguchi A; Hoshino S; Kawami N; Gudis K; Nomura T; Shimizu A; Iwakiri K
    Pathol Res Pract; 2020 Oct; 216(10):153113. PubMed ID: 32853950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric carcinoids after long-term use of a proton pump inhibitor.
    Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
    Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypergastrinemia and gastric enterochromaffin-like cells.
    Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
    Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.
    Lee L; Ramos-Alvarez I; Ito T; Jensen RT
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.
    Trinh VQ; Shi C; Ma C
    Histopathology; 2020 Dec; 77(6):865-876. PubMed ID: 32702178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
    Richards ML; Gauger P; Thompson NW; Giordano TJ
    World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
    Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
    J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
    Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
    Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
    Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
    Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.
    Peghini PL; Annibale B; Azzoni C; Milione M; Corleto VD; Gibril F; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
    Gastroenterology; 2002 Jul; 123(1):68-85. PubMed ID: 12105835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric enterochromaffin-like cell changes in multiple endocrine neoplasia type 1.
    Manoharan J; Anlauf M; Albers MB; Denzer UW; Mintziras I; Wächter S; Di Fazio P; Bollmann C; Bartsch DK
    Clin Endocrinol (Oxf); 2021 Sep; 95(3):439-446. PubMed ID: 33506527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.
    Song H; Zhu J; Lu D
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010623. PubMed ID: 25464111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
    Hirschowitz BI; Haber MM
    Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterochromaffin-like Cell Hyperplasia-Associated Gastric Neuroendocrine Tumors May Arise in the Setting of Proton Pump Inhibitor Use.
    Rais R; Trikalinos NA; Liu J; Chatterjee D
    Arch Pathol Lab Med; 2022 Mar; 146(3):366-371. PubMed ID: 34283890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
    Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
    Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids.
    Debelenko LV; Emmert-Buck MR; Zhuang Z; Epshteyn E; Moskaluk CA; Jensen RT; Liotta LA; Lubensky IA
    Gastroenterology; 1997 Sep; 113(3):773-81. PubMed ID: 9287968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.
    Ko Y; Tang J; Sanagapalli S; Kim BS; Leong RW
    Expert Opin Drug Saf; 2016 Jan; 15(1):53-63. PubMed ID: 26560097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.
    Tomassetti P; Salomone T; Migliori M; Campana D; Corinaldesi R
    Drugs Aging; 2003; 20(14):1019-34. PubMed ID: 14651442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of gastric and duodenal neuroendocrine tumors.
    Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
    World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.